Anticoagulative effects of the inhaled low molecular weight heparin certoparin in healthy subjects.

@article{Scheuch2007AnticoagulativeEO,
  title={Anticoagulative effects of the inhaled low molecular weight heparin certoparin in healthy subjects.},
  author={Gerhard Scheuch and Peter John GlaxoSmithKline Brand and Thomas Meyer and Christine Herpich and Bernhard Muellinger and Jakub Brom and Gottfried Weidinger and Martin Kohlh{\"a}ufl and Karl Haeussinger and Michael Spannagl and Wolfgang Schramm and Ruediger Siekmeier},
  journal={Journal of physiology and pharmacology : an official journal of the Polish Physiological Society},
  year={2007},
  volume={58 Suppl 5 Pt 2},
  pages={
          603-14
        }
}

• Gerhard Scheuch, Peter John GlaxoSmithKline Brand, +9 authors Ruediger Siekmeier
• Published in
  Journal of physiology and pharmacology : an…
  2007

Inhalation of heparin results in local antiinflammatory and antifibrotic effects and an inhibition of blood coagulation. A number of experimental and clinical studies demonstrated that inhalant administration of heparin or low molecular weight heparin (LMWH) is a feasible and save tool for anticoagulative treatment. However, heparin and LMWH differ in respect to their molecular weight, pulmonary absorption, and principle of their anticoagulative pattern. In our study we investigated the… CONTINUE READING

View on PubMed

Save to Library

Create Alert

Cite